NCOA5, nuclear receptor coactivator 5, 57727

N. diseases: 53; N. variants: 5
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.030 Biomarker disease BEFREE In conclusion, our findings provide a mechanistic insight into the role of NCOA5 in HCC progression. 29626478 2018
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.030 GeneticVariation disease BEFREE Collectively, our data show that the T445A variation impairs the ability of NCOA5 to inhibit growth of HCC, suggesting that this variation may have potential to increase susceptibility to HCC comorbid with T2D. 28137631 2017
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.030 Biomarker disease BEFREE These findings suggest that NCOA5 is a haploinsufficient tumor suppressor and that NCOA5 deficiency increases susceptibility to both glucose intolerance and HCC, partially by increasing IL-6 expression. 24332041 2013